{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:28:54Z","timestamp":1787023734507,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10067-026-08238-0","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:39:18Z","timestamp":1782376758000},"page":"4937-4945","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uveitis in spondyloarthritis: clinical patterns and differences between axial and peripheral forms"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8538-980X","authenticated-orcid":false,"given":"Elena Migu\u00e9lez","family":"S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Molinari","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Tornero","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ventura","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Navarro","family":"Comp\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle","family":"Schlinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"de Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro Balsa","family":"Criado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Peiteado","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"8238_CR1","unstructured":"D\u00edaz-Valle D, Fern\u00e1ndez RM, Del Castillo JMB (2007) Actualizaci\u00f3n en el tratamiento de la uve\u00edtis. In: Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Epidemiolog\u00eda e importancia de las uve\u00edtis. Principios b\u00e1sicos del tratamiento y algoritmo terap\u00e9utico en las uve\u00edtis end\u00f3genas autoinmunes. p 11\u201318, 39\u201346"},{"issue":"9","key":"8238_CR2","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/bjo.80.9.844","volume":"80","author":"MS Suttorp-Schulten","year":"1996","unstructured":"Suttorp-Schulten MS, Rothova A (1996) The possible impact of uveitis on blindness: a literature survey. Br J Ophthalmol 80(9):844\u2013848. https:\/\/doi.org\/10.1136\/bjo.80.9.844","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"8238_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/bjo.80.4.332","volume":"80","author":"A Rothova","year":"1996","unstructured":"Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A (1996) Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80(4):332\u2013336. https:\/\/doi.org\/10.1136\/bjo.80.4.332","journal-title":"Br J Ophthalmol"},{"key":"8238_CR4","doi-asserted-by":"publisher","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140(3):509\u201316. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057","DOI":"10.1016\/j.ajo.2005.03.057"},{"issue":"5","key":"8238_CR5","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1093\/rheumatology\/7809003","volume":"64","author":"H Maldonado-Ficco","year":"2025","unstructured":"Maldonado-Ficco H, L\u00f3pez-Medina C, Perez-Alamino R, Waimann CA, Maldonado-Cocco JA, Molt\u00f3 A, Dougados M et al (2025) Prevalence and incidence of uveitis in patients with spondyloarthritis: the impact of the biologics era. Data from the international ASAS-COMOSPA study. Rheumatology (Oxford) 64(5):2618\u20132624. https:\/\/doi.org\/10.1093\/rheumatology\/7809003","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"8238_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.31138\/mjr.34.1.24","volume":"34","author":"A Pandey","year":"2023","unstructured":"Pandey A, Ravindran V (2023) Ocular manifestations of spondyloarthritis. Mediterr J Rheumatol 34(1):24\u201329. https:\/\/doi.org\/10.31138\/mjr.34.1.24","journal-title":"Mediterr J Rheumatol"},{"issue":"6","key":"8238_CR7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.berh.2018.08.002","volume":"31","author":"SM Sharma","year":"2017","unstructured":"Sharma SM, Jackson D (2017) Uveitis in the spondyloarthopathies. Best Pract Res Clin Rheumatol 31(6):846\u2013862. https:\/\/doi.org\/10.1016\/j.berh.2018.08.002","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"8238_CR8","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s10067-006-0403-2","volume":"26","author":"CH Chen","year":"2007","unstructured":"Chen CH, Lin KC, Chen HA, Liao HT, Liang TH, Wang HP, Chou CT (2007) Association of acute anterior uveitis with disease activity, functional ability, and physical mobility in patients with ankylosing spondylitis: a cross-sectional study of Chinese patients in Taiwan. Clin Rheumatol 26(6):953\u2013957. https:\/\/doi.org\/10.1007\/s10067-006-0403-2","journal-title":"Clin Rheumatol"},{"key":"8238_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ajo.2025.03.032","volume":"276","author":"N Kirupaharan","year":"2025","unstructured":"Kirupaharan N, Marshall RF, Spangler MD, Armbrust KR, Berkenstock MK (2025) Incidence and prevalence of uveitis and associated ocular complications in the United States TriNetX Database. Am J Ophthalmol 276:30\u201339. https:\/\/doi.org\/10.1016\/j.ajo.2025.03.032","journal-title":"Am J Ophthalmol"},{"key":"8238_CR10","doi-asserted-by":"publisher","first-page":"608134","DOI":"10.3389\/fimmu.2020.608134","volume":"11","author":"D Wakefield","year":"2021","unstructured":"Wakefield D, Clarke D, McCluskey P (2021) Recent developments in HLA B27 anterior uveitis. Front Immunol 11:608134. https:\/\/doi.org\/10.3389\/fimmu.2020.608134","journal-title":"Front Immunol"},{"issue":"6","key":"8238_CR11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2008.102283","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Listing J, Akkoc N, Brandt J, Braun J et al (2009) The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777\u2013783. https:\/\/doi.org\/10.1136\/ard.2008.102283","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"8238_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.reuma.2018.07.014","volume":"16","author":"V Navarro-Comp\u00e1n","year":"2018","unstructured":"Navarro-Comp\u00e1n V, Ot\u00f3n T, Loza E, Almod\u00f3var R, Ariza-Ariza R, Bautista-Molano W, Burgos-Vargas R et al (2018) ASAS consensus on Spanish nomenclature for spondyloarthritis. Reumatolog\u00eda Cl\u00ednica 16(5):333\u2013338","journal-title":"Reumatolog\u00eda Cl\u00ednica"},{"issue":"10","key":"8238_CR13","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1002\/art.40568","volume":"70","author":"JT Rosenbaum","year":"2018","unstructured":"Rosenbaum JT, Dick AD (2018) The eyes have it. Arthritis Rheumatol 70(10):1533\u20131543. https:\/\/doi.org\/10.1002\/art.40568","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"8238_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/ard.59.1.67","volume":"59","author":"ES Paiva","year":"2000","unstructured":"Paiva ES, Macaluso DC, Edwards A, Rosenbaum JT (2000) Characterisation of uveitis in patients with psoriatic arthritis. Ann Rheum Dis 59(1):67\u201370. https:\/\/doi.org\/10.1136\/ard.59.1.67","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"8238_CR15","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","volume":"21","author":"SR Vavricka","year":"2015","unstructured":"Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G (2015) Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 21(8):1982\u20131992. https:\/\/doi.org\/10.1097\/MIB.0000000000000392","journal-title":"Inflamm Bowel Dis"},{"issue":"32","key":"8238_CR16","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.3748\/wjg.v23.i32.5836","volume":"23","author":"LL Troncoso","year":"2017","unstructured":"Troncoso LL, Biancardi AL, de Moraes HV Jr, Zaltman C (2017) Ophthalmic manifestations in patients with inflammatory bowel disease: a review. World J Gastroenterol 23(32):5836\u20135848. https:\/\/doi.org\/10.3748\/wjg.v23.i32.5836","journal-title":"World J Gastroenterol"},{"issue":"4","key":"8238_CR17","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s10620-024-08454-5","volume":"70","author":"M Harbord","year":"2025","unstructured":"Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM et al (2025) The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease: Part 1\u2014Pathogenesis and clinical features. Dig Dis Sci 70(4):1467\u20131476. https:\/\/doi.org\/10.1007\/s10620-024-08454-5","journal-title":"Dig Dis Sci"},{"key":"8238_CR18","doi-asserted-by":"publisher","unstructured":"De Vicente Delm\u00e1s A, S\u00e1nchez-Bilbao L, Calvo-R\u00edo V, Mart\u00ednez-L\u00f3pez D, Herrero-Morant A, Gal\u00edndez-Agirregoikoa et al (2023) Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review. RMD Open 9(1):e002781. https:\/\/doi.org\/10.1136\/rmdopen-2022-002781","DOI":"10.1136\/rmdopen-2022-002781"},{"key":"8238_CR19","doi-asserted-by":"publisher","unstructured":"Peluso R, Di Minno MND, Iervolino S, Manguso F, Tramontano G, Ambrosino P, Scarpa R (2013) Enteropathic spondyloarthritis: from diagnosis to treatment. Clin Dev Immunol 631408. https:\/\/doi.org\/10.1155\/2013\/631408","DOI":"10.1155\/2013\/631408"},{"key":"8238_CR20","unstructured":"Spanish Society of Rheumatology (SER) recommendations for the treatment of uveitis [Internet]. Reumatolog\u00eda Cl\u00ednica.Available from: https:\/\/www.reumatologiaclinica.org\/es-recomendaciones-ser-sobre-el-tratamiento-articulo-S1699258X23001754. Accessed 12 Aug 2025"},{"issue":"2","key":"8238_CR21","doi-asserted-by":"publisher","first-page":"102731","DOI":"10.1016\/j.autrev.2020.102731","volume":"20","author":"M Br\u00fcner","year":"2021","unstructured":"Br\u00fcner M, Dige A, Loft AG, Laurberg TB, Agnholt JS, Clemmensen K et al (2021) Spondylitis-psoriasis-enthesitis-enterocolitis-dactylitis-uveitis-peripheral synovitis (SPEED-UP) treatment. Autoimmun Rev 20(2):102731. https:\/\/doi.org\/10.1016\/j.autrev.2020.102731","journal-title":"Autoimmun Rev"},{"key":"8238_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7812\/TPP\/17-041","volume":"22","author":"N Gupta","year":"2018","unstructured":"Gupta N, Agarwal A (2018) Management of uveitis in spondyloarthropathy: current trends. Permanente J 22:17\u2013041. https:\/\/doi.org\/10.7812\/TPP\/17-041","journal-title":"Permanente J"},{"issue":"6","key":"8238_CR23","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.reuma.2017.08.008","volume":"14","author":"J Gratac\u00f3s","year":"2018","unstructured":"Gratac\u00f3s J, del Campo D, Fontecha P, Fern\u00e1ndez-Carballido C, JuanolaRoura X, Linares Ferrando LF, de Miguel ME et al (2018) Recommendations by the Spanish society of rheumatology on the use of biological therapies in axial spondyloarthritis. Reumatol Clin (Engl Ed) 14(6):320\u2013333. https:\/\/doi.org\/10.1016\/j.reuma.2017.08.008","journal-title":"Reumatol Clin (Engl Ed)"},{"issue":"1","key":"8238_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s10792-024-03405-1","volume":"45","author":"A Avello-Gorostidi","year":"2025","unstructured":"Avello-Gorostidi A, Hernanz I, Robles-Barrena I, Olivas-Vergara O, Borges PE, Arconada-L\u00f3pez C, Romero-Bueno F et al (2025) Efficacy of sulfasalazine on recurrent acute anterior uveitis: a three-year follow-up. Int Ophthalmol 45(1):36. https:\/\/doi.org\/10.1007\/s10792-024-03405-1","journal-title":"Int Ophthalmol"},{"issue":"11","key":"8238_CR25","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1007\/s00296-023-05424-0","volume":"43","author":"N Kougkas","year":"2023","unstructured":"Kougkas N, Magiouf K, Gialouri CG, Evangelatos G, Pappa M, Dimouli A, Iliopoulos A et al (2023) Higher frequency but similar recurrence rate of uveitis episodes in axial spondylarthritis compared to psoriatic arthritis. A multicentre retrospective study. Rheumatol Int 43(11):2081\u20132088. https:\/\/doi.org\/10.1007\/s00296-023-05424-0","journal-title":"Rheumatol Int"},{"issue":"3","key":"8238_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/sj.eye.6700156","volume":"14","author":"JM Benitez-Del-Castillo","year":"2000","unstructured":"Benitez-Del-Castillo JM, Garcia-Sanchez J, Iradier T, Ba\u00f1ares A (2000) Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis. Eye 14(3):340\u2013343. https:\/\/doi.org\/10.1038\/sj.eye.6700156","journal-title":"Eye"},{"issue":"6","key":"8238_CR27","first-page":"1277","volume":"30","author":"S Mu\u00f1oz-Fern\u00e1ndez","year":"2003","unstructured":"Mu\u00f1oz-Fern\u00e1ndez S, Hidalgo V, Fern\u00e1ndez-Mel\u00f3n J, Schlincker A, Bonilla G, Ruiz-Sancho D et al (2003) Sulfasalazine reduces the number of flares of acute anterior uveitis over one year. J Rheumatol 30(6):1277\u20131279","journal-title":"J Rheumatol"},{"issue":"1","key":"8238_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-024-03405-1","volume":"45","author":"A Avello-Gorostidi","year":"2025","unstructured":"Avello-Gorostidi A, Hernanz I, Robles-Barrena I, Olivas-Vergara O, Borges PE, Arconada-L\u00f3pez C, Romero-Bueno F, S\u00e1nchez-Pernaute O, Carre\u00f1o E (2025) Efficacy of sulfasalazine on recurrent acute anterior uveitis: a three-year follow-up. Int Ophthalmol 45(1):36. https:\/\/doi.org\/10.1007\/s10792-024-03405-1","journal-title":"Int Ophthalmol"},{"key":"8238_CR29","doi-asserted-by":"publisher","unstructured":"Zu Hoerste MM, Walscheid K, Tappeiner C, Zurek-Imhoff B, Heinz C, Heiligenhaus A (2018) The effect of methotrexate and sulfasalazine on the course of HLA-B27-positive anterior uveitis: results from a retrospective cohort study. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 256(10):1985\u20131992. https:\/\/doi.org\/10.1007\/s00417-018-4082-x","DOI":"10.1007\/s00417-018-4082-x"},{"issue":"7","key":"8238_CR30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1080\/09273948.2017.1411518","volume":"26","author":"F Mackensen","year":"2018","unstructured":"Mackensen F, Heinz C, Jakob E, Grewing V, Lorenz HM, Heiligenhaus, et al (2018) Randomized controlled study to evaluate the efficacy of adalimumab in patients with different forms of refractory uveitis. Ocular Immunol Inflamm 26(7):1015\u20131022. https:\/\/doi.org\/10.1080\/09273948.2017.1411518","journal-title":"Ocular Immunol Inflamm"},{"issue":"9","key":"8238_CR31","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.3899\/jrheum.131347","volume":"41","author":"JC van Denderen","year":"2014","unstructured":"van Denderen JC, Visman IM, Nurmohamed MT, Suttorp-Schulten MS, van der Horst-Bruinsma IE (2014) Adalimumab significantly reduces the recurrence rate of anterior uveitis in patients with ankylosing spondylitis. J Rheumatol 41(9):1843\u20131848. https:\/\/doi.org\/10.3899\/jrheum.131347","journal-title":"J Rheumatol"},{"issue":"6","key":"8238_CR32","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/acr.22848","volume":"68","author":"M Rudwaleit","year":"2016","unstructured":"Rudwaleit M, Rosenbaum JT, Landew\u00e9 R, Marzo-Ortega H, Sieper J, van der Heijde D, Davies O et al (2016) Observed incidence of uveitis following certolizumab pegol treatment in patients with axial spondyloarthritis. Arthritis Care Res 68(6):838\u2013844. https:\/\/doi.org\/10.1002\/acr.22848","journal-title":"Arthritis Care Res"},{"issue":"12","key":"8238_CR33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/rheumatology\/keu266","volume":"53","author":"V Calvo-R\u00edo","year":"2014","unstructured":"Calvo-R\u00edo V, Blanco R, Beltr\u00e1n E, S\u00e1nchez-Burs\u00f3n J, Mesquida M, Ad\u00e1n A et al (2014) Anti-TNF therapy in refractory uveitis associated with spondyloarthritis. Rheumatology (Oxford) 53(12):222\u2013229","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"8238_CR34","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1136\/annrheumdis-2016-210634","volume":"76","author":"E Lie","year":"2017","unstructured":"Lie E, Lindstr\u00f6m U, Zverkova-Sandstr\u00f6m T, Olsen IC, Forsblad-d\u2019Elia H, Askling J, Kapetanovic MC et al (2017) Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register. Ann Rheum Dis 76(9):1515\u20131521. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210634","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8238_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13075\/E2\/80\/91021\/E2\/80\/9102542\/E2\/80\/910","volume":"23","author":"D Roche","year":"2021","unstructured":"Roche D, Badard M, Boyer L, Lafforgue P, Pham T (2021) Incidence of anterior uveitis in patients with axial spondyloarthritis treated with anti-TNF or anti-IL17A: a systematic review, a pairwise and network meta-analysis of randomized controlled trials. Arthritis Res Ther 23(1):192. https:\/\/doi.org\/10.1186\/s13075\/E2\/80\/91021\/E2\/80\/9102542\/E2\/80\/910","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"8238_CR36","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1136\/ard-2024-225933","volume":"83","author":"MA Brown","year":"2024","unstructured":"Brown MA, Rudwaleit M, van Gaalen FA, Haroon N, Gensler LS, Fleurinck C, Marten A, Massow U, de Peyrecave N, Vaux T, White K, Deodhar A, van der Horst-Bruinsma I (2024) Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b\/3 trials. Ann Rheum Dis 83(12):1722\u20131730. https:\/\/doi.org\/10.1136\/ard-2024-225933","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 1","key":"8238_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.31138\/mjr.310725.ect","volume":"37","author":"D Deligeorgakis","year":"2026","unstructured":"Deligeorgakis D, Skouvaklidou E, Skepastianos V, Papadimitriou E, Boutel M, Dimitriadou V, Tsafis K et al (2026) Current and emerging therapies for uveitis in axial spondyloarthritis: a scoping review. Mediterr J Rheumatol 37(Suppl. 1):46\u201357","journal-title":"Mediterr J Rheumatol"},{"issue":"2","key":"8238_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41584-024-01189-3","volume":"21","author":"F Navid","year":"2025","unstructured":"Navid F, Chen L, Bowness P, Colbert RA (2025) HLA-B27 and spondyloarthritis: at the crossroads of innate and adaptive immunity. Nat Rev Rheumatol 21(2):77\u201387. https:\/\/doi.org\/10.1038\/s41584-024-01189-3","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"8238_CR39","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41584-019-0253-9","volume":"15","author":"D McGonagle","year":"2019","unstructured":"McGonagle D, Watad A, Sharif K (2019) The IL-23\/IL-17 pathway in spondyloarthritis: what is the evidence? Nat Rev Rheumatol 15(9):521\u2013532. https:\/\/doi.org\/10.1038\/s41584-019-0253-9","journal-title":"Nat Rev Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08238-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08238-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08238-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:16:51Z","timestamp":1787023011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08238-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["8238"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08238-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"1 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Drug Research Ethics Committee of Hospital Universitario La Paz and was conducted in accordance with Good Clinical Practice and the ethical principles of the Declaration of Helsinki and its subsequent amendments.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors give their consent for the publication of this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}